Career DevelopmentForum

Is Final Signatory an actual formal qualification?

454
5
8 months ago
My links

I’m interested in a career as a Final Signatory. I would like to know if this is an actual formal accreditation or is it more of an informal title that varies from company to company? 

2 Answers

Answer question
PharmAffinity Forum: Is Final Signatory an actual formal qualification?

Its not a qualification. Its more of a status. Being a final signatory for one company doesn't mean you can be a final signatory at another company, they will usually ask you to sit their internal exam before submitting your name to the PMCPA.

Anonymous
Answered 8 months ago
Add reply
PharmAffinity Forum: Is Final Signatory an actual formal qualification?

Gaining a final signatory status is not a formal qualification. It requires learning about the application of the ABPI code of practice through studying, mentoring and hands on experience. Usually pharmaceutical companies would require their final signatories to undergo a test before submitting their name to the PMCPA to be a signatory on behalf of the company. The test can consist of different elements there may be a written part including aspects of understanding code requirements, the clauses, reviewing materials in addition to commenting on code cases, there can also be a viva as part of the assessment. Assessments can last between 30 minutes to 2 hours depending on the company, posisiton of the signatory and their experience. 

Gina BariahGlobal Medical Director, GSK
Answered 8 months ago

I am aware of final signatory assessments lasting 3 hours!

8 months ago
Anonymous

Who would do the assessment? Is this done in the company or externally?

8 months ago
Anonymous

Both can be possible. Sometimes companies will have an internal assessment which is conducted by someone from the medical/compliance team. And sometimes companies will outsource to 3rd parties who specialise in signatory training and assessments.

8 months ago
Gina Bariah
Add reply

Answer question

Share a link to this question via email, Twitter or Facebook.